e.g. Tata motors, Reliance MF, 500570

Bliss GVS Pharma Ltd. - Research Center

506197 BLISSGVS Group (B) BSE data
 
Back to Company Page
Statement:

Profit loss account

(Rs crore)
Mar ' 25 Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21
Income
Operating income 667.20 605.46 598.34 636.36 465.51
Expenses
Material consumed 346.11 299.47 314.90 343.94 253.30
Manufacturing expenses 9.76 8.81 5.80 7.09 6.99
Personnel expenses 99.42 82.59 72.54 65.06 58.61
Selling expenses 1.61 0.99 0.50 0.14 0.17
Adminstrative expenses 118.73 106.43 114.45 110.92 54.98
Expenses capitalised - - - - -
Cost of sales 575.62 498.29 508.18 527.16 374.05
Operating profit 91.59 107.17 90.16 109.20 91.46
Other recurring income 36.22 33.50 50.77 32.63 17.68
Adjusted PBDIT 127.80 140.67 140.92 141.83 109.14
Financial expenses 6.58 5.81 10.06 4.32 4.19
Depreciation 27.05 23.52 15.17 13.85 13.76
Other write offs - - - - -
Adjusted PBT 94.17 111.34 115.69 123.66 91.19
Tax charges 25.20 19.61 30.21 33.74 23.69
Adjusted PAT 68.97 91.73 85.48 89.92 67.50
Non recurring items -0.56 -41.24 -0.67 3.05 0.52
Other non cash adjustments - - - - -
Reported net profit 68.41 50.49 84.81 92.97 68.02
Earnigs before appropriation 960.98 896.67 850.15 769.19 681.38
Equity dividend 5.25 5.21 5.19 5.18 5.16
Preference dividend - - - - -
Dividend tax - - - - -
Retained earnings 955.74 891.46 844.96 764.02 676.22
Close
Add Bliss GVS Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Bliss GVS Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback